Vaccines for Diarrheal Diseases

위장관염에 대한 백신

  • Park, Su Eun (Department of Pediatrics, School of Medicine, Pusan National University)
  • 박수은 (부산대학교 의학전문대학원 소아과학교실)
  • Received : 2009.06.30
  • Accepted : 2009.12.01
  • Published : 2009.12.25

Abstract

Diarrhea is one of the most common causes of morbidity and mortality in children worldwide. Rotavirus is the most common cause of infectious diarrhea both in developed and developing countries. However, bacterial causes such as Salmonella typhi and Vibrio cholerae still play an important role in developing countries. Newly developed vaccines for rotavirus, S. typhi, and V. choleae are highly immunogenic and safe in children.

Keywords

References

  1. Ruiz-Palacios GM, Perez-Schael I, Velazquez R, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroentsritis. N Engl J Med 2006;354:11-22. https://doi.org/10.1056/NEJMoa052434
  2. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33. https://doi.org/10.1056/NEJMoa052664
  3. CDC. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory committee on immunization Practices (ACIP). MMWR 2009;58(RR-02).
  4. Buttery JP, kirkwood C. Rotavirus vaccines in developed countries. Curr Opin Infect Dis 2007;20:253-8. https://doi.org/10.1097/QCO.0b013e32813aeaac
  5. Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, et al. European society for paediatric infectious disease/European society for paediatric gastroenterology, hepatology, and nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr 2008; 46:615-8. https://doi.org/10.1097/MPG.0b013e31816e213a
  6. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-6. https://doi.org/10.3201/eid1202.050006
  7. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (Rotashield) and intussusception. J Infect Dis 2006;193: 898.
  8. Berstein DI. Live attenuated human rotavirus vaccine, RotarixTM. Semin Pediatr Infect Dis 2006;17:188-94. https://doi.org/10.1053/j.spid.2006.08.006
  9. Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, et al. REST Study Team. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 2007;26:1099-104. https://doi.org/10.1097/INF.0b013e31814521cb
  10. Centers for Disease Control and Prevention (CDC). Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep 2007;56:218-22.
  11. Vesikari T. Rotavirus vaccine. Scand J Infect Dis 2008; 40:691-5. https://doi.org/10.1080/00365540802040570
  12. WHO. Typhoid vaccines: WHO position paper. WHO 2008;6:49-60. http://www.who.int/wer
  13. Fraser A, Paul M, Goldberg E, Ascota CJ, Leibovici L. Typhoid fever vaccines: systematic review and metaanalysis of randomised controlled trials. Vaccine 2007; 25:7848-57. https://doi.org/10.1016/j.vaccine.2007.08.027
  14. DeRoeck D, Ochiai RL, Yang J, Anh DD, Alag V, Clemens JD. Typhoid vaccination: the Asian experience. Expert Rev Vaccines 2008;7:547-60. https://doi.org/10.1586/14760584.7.5.547
  15. Acosta CJ, Galindo CM, Deen JL, Ochiai RL, Lee HJ, von Seidlein L, et al. Vaccines against cholera, typhoid fever and shigellosis for developing countries. Expert Opin Biol Ther 2004;4:1939-51. https://doi.org/10.1517/14712598.4.12.1939
  16. Levine MM. Typhoid fever vaccines. In : Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia : WB Saunders Co, 2004:1057-93.
  17. Sack DA, Lang DR. Cholera vaccines. In : Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia : WB Saunders Co, 2004:905-17.